胸腺五肽注射液不合理用药干预分析

发布时间：2018-06-27 10:43

本文选题：胸腺五肽 + 不合理用药　；参考：《中国临床药理学杂志》2017年07期

【摘要】：目的了解我院胸腺五肽注射液的使用现状。方法通过医院信息系统(HIS系统)调取2016年1月至3月首都医科大学附属北京朝阳医院使用胸腺五肽注射液(1 m L/10 mg)的住院病例903例,对其适应证、用法用量、临床疗效、联合用药等进行分析,通过临床药师对问题科室的干预和发布合理用药专项点评通报对不合理之处进行整改。结果经干预后,我院胸腺五肽注射液使用存在使用指征不明确、用法用量及疗程不规范、疗效不确切等问题均得到了明显地改善。胸腺五肽注射液使用量由2016年第1季度的12449支下降至第2季度的10142支。结论临床药师下科室干预和合理用药专项点评是有效的干预措施,临床药师在促进医院合理用药方面具有重要作用。
[Abstract]:Objective to understand the present situation of thymic pentapeptide injection in our hospital. Methods from January to March 2016, 903 inpatients with thymopeptide injection (1 mL / 10 mg) were collected from Beijing Chaoyang Hospital affiliated to Capital Medical University from January to March 2016. Through the intervention of the clinical pharmacist to the problem department and the issuance of the special comment on rational drug use, the irrationality was corrected. Results after intervention, the use of thymic pentapeptide injection in our hospital had some problems, such as unclear indications, irregular dosage and course of treatment, and imprecise curative effect. The amount of thymopeptide injection decreased from 12449 in the first quarter of 2016 to 10142 in the second quarter. Conclusion intervention by clinical pharmacists and special comments on rational use of drugs are effective interventions, and clinical pharmacists play an important role in promoting rational use of drugs in hospitals.
【作者单位】：首都医科大学附属北京朝阳医院药事部;
【分类号】：R979.5

【相似文献】